1Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4255, USA. shil@pt.cyanamid.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
The U.S. National Cancer Institute (NCI) analyzes anticancer drug activity across 60 cell lines to identify new drug candidates. This large-scale screening provides insights into cancer drug mechanisms and targets.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: